REFERENCE FORMULA
Reference formula
Reference basis: 1000 g τελικού παρασκευάσματος /1000 g finished preparation
| Ingredient | Source quantity | Scaled quantity |
|---|---|---|
| Hamamelis virginiana leaves | 200 g | — |
| Ethanol 60% v/v extraction solvent | q.s. as required | — |
Prerequisite formulations
No separate prerequisite monograph is listed.
Documentation
Preparation description
Brown or greenish-brown liquid;1–9 volumes of water cause slight turbidity. This is an extracted herbal preparation, not a solution of a purified active. [1]
Action and use
The French leaf tincture 1:5/60% v/v does not match the HMPC fresh-leaf tincture 1:10/45% v/v. It is documented as a herbal reference preparation/intermediate. A dose or indication from a different extract is not assigned. Product-specific clinical justification is required before patient supply. [1], [6]
Specifications
Final ethanol 54–58% v/v; dry residue 3.0–4.0%. These apply to the finished extract, not the nominal extracting-solvent strength. The monograph-specific chromatographic identity is required. [1]
Light
The source requires light protection. Select light-protective glass; brief processing in clear equipment is not evidence of photostability. No permissible exposure duration is established. [1]
Air and oxidation
Water and solubility
Brown or greenish-brown liquid;1–9 volumes of water cause slight turbidity. Dilution with water or an aqueous vehicle therefore creates a different preparation requiring reassessment of dispersion, dose uniformity and BUD. Do not correct evaporation losses by adding water without reassessing alcohol strength. [1], [2]
Humidity
Temperature
pH and compatibility
Other interactions
Ingredient-specific information
Staff protection
Risk assessment
Critical failure modes: wrong species/part; confusing 60% extracting solvent with 54–58% final ethanol; incorrect 1:5 ratio; solvent loss; precipitation after dilution; and importing doses from a non-equivalent extract. Record identity, final mass, yield, alcohol assay and fingerprint before release. Numerical risk scoring belongs to the local assessment. HMPC identifies hypersensitivity and reports allergic contact dermatitis for witch-hazel leaf preparations. Consider these clinically without transferring an unsupported dose or pregnancy/lactation safety claim to this different extract. [1], [2], [5], [6]
Compounding conditions
For scale factor k = desired final mass/1000 g, charge 200×k g of herb. The filtered tincture has final mass 1000×k g. Additional solvent is required for extraction; its amount is not calculated by subtracting the herb mass from final yield. Record lots, comminution method and actual recovery. [1], [2]
BUD rationale
The French monograph gives no use period, and no study was identified covering this exact formula, container and microbiological suitability. Final ethanol 54–58% v/v is neither a measured aw nor, alone, a preservative-efficacy test. Conservatively assess it as an aqueous product with unknown aw. The 35-day default for justified preserved aqueous products, or 14 days at 2–8 °C for unpreserved products, applies only after the corresponding category and physical compatibility are supported. No operational numerical BUD is assigned here. A recorded decision for this extraction/container is required, limited by the earliest relevant expiry. [1], [3], [5]
Prerequisites
Equipment
Compounding method
1. Identify and suitably comminute 200 g of the specified herb.
2. Percolate with 60% v/v ethanol using a controlled local wetting, packing and flow procedure.
3. Obtain 1000 g tincture as specified, homogenise and test. The source provides no numerical flow rate or total solvent volume.
4. Package after confirming specifications. [1], [2]
2. Percolate with 60% v/v ethanol using a controlled local wetting, packing and flow procedure.
3. Obtain 1000 g tincture as specified, homogenise and test. The source provides no numerical flow rate or total solvent volume.
4. Package after confirming specifications. [1], [2]
Observations
Container and packaging
Quality control
Tannin/flavone identification and TLC with gallic acid, quercetin and ethyl gallate; apply the source system-separation criterion. Determine dry residue 3.0–4.0% on 2.00 g after evaporation and 3 hours drying at 100–105 °C. Assay final ethanol 54–58% v/v. Apply the relevant general microbiological/herbal identity framework; no numerical limit absent from the specific source is invented. [1], [5]
Storage
Dispensing
Each supply requires an explicit route, indication and patient-specific dose justified for this exact extract. The witch-hazel HMPC monograph covers local/oromucosal or rectal uses of specified preparations; swallowed oral use cannot be inferred. A pharmacopoeial recipe does not automatically establish suitability in children, pregnancy or breastfeeding. [1], [6]
Labelling
Witch-hazel tincture
Final ethanol: actual____% v/v (specification 54–58%).
Use only as specified by the responsible pharmacist. Protect from light; close tightly.
Route/dose____ Lot____ Quantity____
Prepared____ Use by____ Approved temperature____
Contains ethanol. Keep from children and ignition sources. [1], [2], [4], [6]
Final ethanol: actual____% v/v (specification 54–58%).
Use only as specified by the responsible pharmacist. Protect from light; close tightly.
Route/dose____ Lot____ Quantity____
Prepared____ Use by____ Approved temperature____
Contains ethanol. Keep from children and ignition sources. [1], [2], [4], [6]
v9_controls
The numeric value is a literature reference ceiling subject to its specific conditions. No actual batch BUD has been assigned and no aw measurements have been produced. The exact formula, prerequisites, container, storage and quality evidence require approval for the actual application. The BUD clock starts when compounding begins. Use the shortest applicable supported limit and assess in-use dating separately. USP categories are a technical framework and are not presented as Greek legislation.
Independent Greek/English scientific compilation; not an official ANSM translation or endorsement.
Sources and references
- ANSM — Teinture d'hamamelis (1989) (14/02/2012)1989p 1 opening recipe; p 1 opening procedure; pp 1–2 Characters/Identification/Test; 2 ConservationExact master formula, preparation, specifications and stated storage2026-10-14
- PIC/S — Guide to Good Practices for the Preparation of Medicinal Products in Healthcare EstablishmentsPE 010-4, 2014Chapters 3–6; Annex 2Process records, facilities, contamination control and release; not a product stability study2026-10-13
- USP expert presentation — Nonsterile Compounding: Beyond-use dates14 September 2023PDFpp 10–11, slides 19–22Public official expert explanation of USP 795 default categories; no exact-product experimental evidence2026-10-13
- INRS — Éthanol, fiche toxicologique 48November 2019pp 1–3 and recommendationspp 7–9Ethanol identity, volatility, flammability and handling; pure-substance properties are not finished-product measurements2026-10-13
- EMA — Guideline on quality of herbal medicinal products/traditional herbal medicinal productsEMA/HMPC/CHMP/CVMP/201116/2005 Rev 3;18 January 2022Herbal-substance/preparation control, specifications and stability sectionsBotanical identity, fingerprints, extraction specifications and stability principles2026-10-13
- EMA/HMPC — Hamamelis virginiana L., foliumEMA/HMPC/114586/2008; adopted 2009§2 preparations;§4.1–4.9Fresh/dried leaf and extraction-solvent distinctions; no automatic dose transfer2026-10-13
- USP — General Chapter <795> Frequently Asked QuestionsNovember 1, 2023 FAQ; rechecked 14 October 2026Questions 52, 54–56, 61, 64–66General category/extension rules only; not exact-product stability evidence.2026-10-14